ŽR‰บ—D‹BF–ผ—_‹ณŽ๖EˆใŠw”ŽŽm

Œค‹†•ช–์F–ฦ‰u‰ž“šAƒTƒCƒgƒJƒCƒ“AŽฉŒศ–ฦ‰uŽพŠณAƒAƒŒƒ‹ƒM[ŽพŠณAŽ๎แ‡–ฦ‰u

Œค‹†‹ฦัF

1) Lin, J.Q., Yoshida, Y. and Yamashita, U.: Suppressive effect of reactive oxygen species on CD40-indnced B cell activation. FEBS Letters, inpress, 2007.

2) Mise-Omata, S., Kuroda, E., Niikura, J., Yamashita, U., Obata, Y. and Doi, T.S.: the proximal kB site in IL-23p19 promoter is responsible for the trans eruption dependent on RelA and c-Rel. J. Immunology, in press, 2007.

3) Nakano, Y., Kuroda, E., Kito, T., Uematsu, S., Akira, S., Yokota, A., Nishizawa, S. and Yamashita, U.: Glioma-deriued soluble factors induce prostaglandin E2 synthesis and mPGES-I expression in murine microglia, J. Neurosurgery, in press, 2007.

4) Kuroda, E., Noguchi, J., Doi, T., Uematsu, S., Akira, S. and Yamashita, U.: IL-3 is an important differentiation facter for the development of prostaglandin E2-producing macrophages between@C57BL/6@and@BALB/c nice. Eur. J. Immunology 37: 2185-2195, 2007.

5) Horita, H., Kuroda, E., Hachisuga, T., Kashimura, M. and Yamashita, U.: Induction of prostaglandin E2 production by leukemia inhibitory factor promotes migration of first trimester extravillous trophoblast cell line, HTR-8/SVneo. Human Reproduction, 22:1081-1089, 2007.

6) Yoshida, Y., Lin, J.Q., Nakano, Y., Ueno, S., Ohmori, S., Fueta, Y., Ishidao, T., Kunugita, N., Yamashita, U. and Hori. H.: 1-BP inhibits NF-?B activity and Bcl-xL expression in astrocytes in vitro and reduces Bcl-xL expression in the brain of rats in vivo. Neurotoxicology, 28:381-386,2007.

7) Nakano. Y., Kuroda, E., Kito. T., Yokota, A. and Yamashita, U.: Induction of macrophagic prostaglandin E2 synthesis by glioma cells. J. Neurosurgery, 104:574-582,2006.

8) Kuroda, E., Noguchi, J., Doi, T., Yoshida, Y., Mise-Omata, S. and Yamashita, U.: Strain difference in murine macrophage functions : Prostaglandins as amarher proceedings of the International Symposium on Low-Dose Radiation Exposure and Bio-Defeuse system. P.37-39,2006.

9) Okada, K., Yamashita, U. and Tsuji, S.: Cyclooxyglnase system contribute to the maintenance of post convulsive period of epileptic phenomena in the genetically epileptic M1 mice. J. UOEH, 28:265-275,2006.

10) Okada, k., Yamashita, U. and Tsuji, S.: Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy-susceptible EL mice: Brain Research, 1102:175-178,2006.

11) Noguchi, J., Kuroda, E. and Yamashita, U.: Strain difference of murine bone marrow-derived mast cell functions. J. Leuk. Biol. 78: 605-611, 2005.

12) Okada, K., Kuroda, E., Yoshida, Y., Yamashita, U., Suzumura, O. and Tsuji, S.: Effects of interferon-b on the cytokine production of astrocytes. J. Neuroimmunol., 159 : 48-54, 2005.

13) Yamashita, U., Sugiura, T., Yoshida, Y. and Kuroda, E.: Effect of endocrine disrupters on macrophage function in vivo. J.UOEH, 27: 1-10, 2005.

14) Okada, K., Yamashita, U. and Tsuji, S.: Modulation of Na+-dependent glutamate transporter of murine astrocytes by inflammatory mediators.@J. UOEH, 27: 150-160, 2005.

15) Sugiura, T., Kuroda, E. and Yamashita, U.: Dysfunction of macrophages in metallothionein-knock out mice. J.UOEH, 26: 193-205. 2004.

16) Yamashita, U., Kuroda, E., Yoshida, Y. and Sugiura, T.: Effect of endocrine disrupters on immune responses in vivo. J. UOEH, 25: 365-374, 2003.

17) Kuroda, E. and Yamashita, U.: Assay system for the effect of prostaglandin E2 in the determination of polarized cytokine production. Methods in Molecular Biology, Vol. 249, Cytokine Protocols, 229-238, 2003.

18) Kuroda, E. and Yamashita, U.: Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role for Th1 activation in Th2-dominan BALB/c mice. J. Immunol., 170 : 757-764, 2003.

19) Sugiura, T. and Yamashita, U.: Strain difference of cadmium-induced cytotoxicity, methallothionein expression and cytokine production in mice. J. UOEH, 25 (Supplement 1) : 197-208, 2003.

20) Kito, T., Kuroda, E. Yokota, A. and Yamashita, U.: Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-g-regulated nitric oxide. J. Neurosurg., 98 : 385-399, 2003.

21) Yamashita, U., Sugiura, T., Yoshida, Y. and Kuroda, E.: Effect of endocrine disrupters on thymocytes in vitro. J.UOEH, 25: 161-170, 2003.

22) Sugiura, T. and Yamashita, U.; Strain difference of cadmium-induced cytotoxicity, methallothionein expression and cytokine production in mice. J.UOEH, 25(S1): 197-208, 2003.

23) Yamashita, U. and Kuroda, E.: Regulation of macrophage-derived chemokine (MDC; CCL22) production. Critical Rev. Immunol., 22 : 105-114, 2002.

24) Kuroda, E., Kito, T. and Yamashita, U.: Reduced expression of STAT4 and IFN-g in macrophages from BALB/c mice. J. Immunol., 168 : 5477-5482, 2002.

25) Kito, T., Kuroda, E., Yokota, A. and Yamashita, U.: Enhancement of macrophage cytotoxicity against murine gliomas by interferon b: increase in nitric oxide production in responses to glioma-derived soluble factors. J. Neurosurg., 97 : 619-626, 2002.

26) Yamada, H., Kuroda, E., Matsumoto, S., Matsumoto, T., Yamada, T. and Yamashita, U.: Prostaglandin E2 down-regulates viable Bacille de Calmette et Guerin-induced bladder cancer cell, MBT-2 in vitro. Clin. Exp. Immunol., 128 : 52-58, 2002.

27) Kuroda, E., Yoshida, Y., Shan, B.E. and Yamashita, U.: Suppression of macrophage interleukin-12 and tumor necrosis factor-a prodution in mice infected with Toxocara canis. Parasite Immunol., 23 : 305-311, 2001.

28) Kuroda, E., Sugiura, T., Okada, K., Zeki, K. and Yamashita, U.: Prostaglandin E2 up-regulates macrophage-derived chemokine (MDC) production, but suppresses interferon-inducible protein-10 (IP-10) production by antigen-presenting cells. J. Immunol., 166 : 1650-1658, 2001.

29) Yoshida, Y., Myozaki, M., Kuroda E. and Yamashita, U. : Cytotoxic effect of an anti-liver monoclonal autoantibody obtained after neonatal thymectomy in mice. J. Autoimmunity, 16: 373-382, 2001.

30) Kishi, H., Kuroda, E., Mishima, H. K. and Yamashita, U.: Role of TGF-b in the retinoic acid-induced inhibition of proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Cell Biol. Int., 25: 1125-1129, 2001.

31) Okada, K., Sugiura, T., Kuroda, E., Tsuji, S. and Yamashita, U.: Phenytoin promotes Th2 type immune response in mice. Clin. Exp. Immunol., 124 : 406-413, 2001.

32) Okada, K., Tsuji, S. and Yamashita, U.: Cycloxgenase-2 expression in the hippocampus from genetically epilepsy susceptible El mice. Brain Res., 894: 332-335, 2001.

33) Kuroda, E., Sugiura, T., Zeki, K., Yoshida, Y. and Yamashita, U.: Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains : A possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol., 164 : 2386-2395, 2000.

34) Sugiura, T. and Yamashita, U. : B cell mitogenic activity of metallothionein in vitro. Int. J. Immunopharmacol., 22 : 113-122, 2000.

35) Okada, K., Yoshida, Y., Sugiura, T., Tanaka, H., Tsuji, S., Yamashita, H. and Yamashita, U.: Reduced interleukin-1 responsiveness in immune system and central nervous system of inbred polydipsic (STR/N) mice. Life Sciences, 66: 1461-1470, 2000.

36) Yamada, H., Matsumoto, S., Matsumoto, T., Yamada, T. and Yamashita, U.: Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2. J. Urology, 164: 526-531, 2000.

37) Yamada, H., Matsumoto, S., Matsumoto, T., Yamada, T. and Yamashita, U.: Enhancing effect of an inhibitor of nitric oxide synthesis on Bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro. Jpn. J. Cancer Res., 91: 534-542, 2000.

38) Shan, B. E., Zeki, K., Sugiura, T. and Yamashita, U.: Chinese medicinal herb, Acanthopanax gracilistylus extract induces cell cycle arrest of human tumor cells in vitro. Jpn. J. Cancer Res., 91: 383-389, 2000.

39) Kawakami, Y., Nagai, N., Ohama, K., Zeki, K., Yoshida, Y., Kuroda, E. and Yamashita, U.: Macrophage-colony stimulating factor inhibits growth of human ovarian cancer cells in vitro. Eur. J. Cancer, 36 : 1991-1997, 2000.



Šw‰๏Šˆ“ฎF“๚–{–ฦ‰uŠw‰๏‰^‰cˆฯˆ๕A“๚–{Š๑ถ’ŽŠw‰๏•]‹cˆ๕A“๚–{ถ‘ฬ–hŒไŠw‰๏@@@@@‰^‰cˆฯˆ๕A•ฤ‘–ฦ‰uŠw‰๏‰๏ˆ๕


---------------------------------------------------------------------------------------------------------


•ถำFˆใŠw•”–ฦ‰uŠw‹ณŽบi‹g“cˆภGj

XV“๚F•ฝฌ21”N4ŒŽ8“๚